Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID Reference, 4th edition, 372 pages

+ the daily Top 10


  Colorectal Neoplasms

  Free Subscription


24.08.2020

2 Am J Surg
1 Ann Surg
2 Ann Surg Oncol
3 BMC Cancer
1 BMC Gastroenterol
1 Br J Cancer
3 Cancer Res
2 Eur J Cancer
2 Gastroenterology
1 Int J Cancer
1 Int J Colorectal Dis
1 J Am Coll Surg
1 J Clin Oncol
1 J Surg Oncol
1 Oncogene
2 PLoS One
1 Proc Natl Acad Sci U S A


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Am J Surg

  1. TATAR C, Benlice C, Delaney CP, Holubar SD, et al
    Modified frailty index predicts high-risk patients for readmission after colorectal surgery for cancer.
    Am J Surg. 2020;220:187-190.
    PubMed         Abstract available

  2. KANTERS AE, Vu JV, Schuman AD, Van Wieren I, et al
    Completeness of operative reports for rectal cancer surgery.
    Am J Surg. 2020;220:165-169.
    PubMed         Abstract available


    Ann Surg

  3. SAO JULIAO GP, Karagkounis G, Fernandez LM, Habr-Gama A, et al
    Conditional Survival in Patients With Rectal Cancer and Complete Clinical Response Managed by Watch and Wait After Chemoradiation: Recurrence Risk Over Time.
    Ann Surg. 2020;272:138-144.
    PubMed         Abstract available


    Ann Surg Oncol

  4. KIM HS, Kim NK
    ASO Author Reflections: Poorest Survival Outcomes in Patients with Right Colon Cancer with KRAS Mutation After Simultaneous Curative-Intent Surgery for Colorectal Cancer Liver Metastases.
    Ann Surg Oncol. 2020 Aug 19. pii: 10.1245/s10434-020-09047.
    PubMed        

  5. XIE H, Kim RD
    ASO Author Reflections: Clinical Utility of Circulating Tumor DNA Analysis in Colorectal Cancer: Current Status.
    Ann Surg Oncol. 2020 Aug 18. pii: 10.1245/s10434-020-09034.
    PubMed        


    BMC Cancer

  6. SCHRAA SJ, van Rooijen KL, van der Kruijssen DEW, Rubio Alarcon C, et al
    Circulating tumor DNA guided adjuvant chemotherapy in stage II colon cancer (MEDOCC-CrEATE): study protocol for a trial within a cohort study.
    BMC Cancer. 2020;20:790.
    PubMed         Abstract available

  7. VAN DEN BERG I, van de Weerd S, Roodhart JML, Vink GR, et al
    Improving clinical management of colon cancer through CONNECTION, a nation-wide colon cancer registry and stratification effort (CONNECTION II trial): rationale and protocol of a single arm intervention study.
    BMC Cancer. 2020;20:776.
    PubMed         Abstract available

  8. BAQAR AR, Wilkins S, Wang W, Oliva K, et al
    Log odds of positive lymph nodes is prognostically equivalent to lymph node ratio in non-metastatic colon cancer.
    BMC Cancer. 2020;20:762.
    PubMed         Abstract available


    BMC Gastroenterol

  9. GAO J, Yang M, Liu L, Guo S, et al
    The aggressive surgical treatment and outcome of a colon cancer patient with COVID-19 in Wuhan, China.
    BMC Gastroenterol. 2020;20:269.
    PubMed         Abstract available


    Br J Cancer

  10. KIM TW, Lee YS, Yun NH, Shin CH, et al
    Correction: MicroRNA-17-5p regulates EMT by targeting vimentin in colorectal cancer.
    Br J Cancer. 2020 Aug 20. pii: 10.1038/s41416-020-1027.
    PubMed         Abstract available


    Cancer Res

  11. UROSEVIC J, Blasco MT, Llorente A, Bellmunt A, et al
    ERK1/2 signaling induces upregulation of ANGPT2 and CXCR4 to mediate liver metastasis in colon cancer.
    Cancer Res. 2020 Aug 19. pii: 0008-5472.CAN-19-4028.
    PubMed         Abstract available

  12. HIDAKA A, Harrison TA, Cao Y, Sakoda LC, et al
    Intake of dietary fruit, vegetables, and fiber and risk of colorectal cancer according to molecular subtypes: A pooled analysis of 9 studies.
    Cancer Res. 2020 Aug 14. pii: 0008-5472.CAN-20-0168.
    PubMed         Abstract available

  13. SHIOKAWA D, Sakai H, Ohata H, Miyazaki T, et al
    Slow-cycling cancer stem cells regulate progression and chemoresistance in colon cancer.
    Cancer Res. 2020 Aug 19. pii: 0008-5472.CAN-20-0378.
    PubMed         Abstract available


    Eur J Cancer

  14. CARDONE C, Blauensteiner B, Moreno-Viedma V, Martini G, et al
    AXL is a predictor of poor survival and of resistance to anti-EGFR therapy in RAS wild-type metastatic colorectal cancer.
    Eur J Cancer. 2020;138:1-10.
    PubMed         Abstract available

  15. STAHLER A, Stintzing S, von Einem JC, Westphalen CB, et al
    Single-nucleotide variants, tumour mutational burden and microsatellite instability in patients with metastatic colorectal cancer: Next-generation sequencing results of the FIRE-3 trial.
    Eur J Cancer. 2020;137:250-259.
    PubMed         Abstract available


    Gastroenterology

  16. WONG CC, Xu J, Bian X, Wu JL, et al
    In Colorectal Cancer Cells With Mutant KRAS, SLC25A22-Mediated Glutaminolysis Reduces DNA Demethylation to Increase WNT Signaling, Stemness, and Drug Resistance.
    Gastroenterology. 2020 Aug 16. pii: S0016-5085(20)35055.
    PubMed         Abstract available

  17. POLLETT A
    Colorectal Cancer: Microsatellite Instability / Mismatch Repair Testing in the Era of Digital Pathology.
    Gastroenterology. 2020 Aug 12. pii: S0016-5085(20)35046.
    PubMed        


    Int J Cancer

  18. TAYLOR JC, Swinson D, Seligmann JF, Birch RJ, et al
    Addressing the variation in adjuvant chemotherapy treatment for colorectal cancer: can a regional intervention promote national change?
    Int J Cancer. 2020 Aug 20. doi: 10.1002/ijc.33261.
    PubMed         Abstract available


    Int J Colorectal Dis

  19. MA T, Wu M, Jia S, Yang L, et al
    Proton pump inhibitors and the risk of colorectal cancer: a systematic review and meta-analysis of observational studies.
    Int J Colorectal Dis. 2020 Aug 18. pii: 10.1007/s00384-020-03717.
    PubMed         Abstract available


    J Am Coll Surg

  20. HILL SS, Chung SK, Meyer DC, Crawford AS, et al
    Impact of Preoperative Care for Rectal Adenocarcinoma on Pathologic Specimen Quality and Postoperative Morbidity: A NSQIP Analysis.
    J Am Coll Surg. 2020;230:17-25.
    PubMed         Abstract available


    J Clin Oncol

  21. CREMOLINI C, Antoniotti C, Stein A, Bendell J, et al
    Individual Patient Data Meta-Analysis of FOLFOXIRI Plus Bevacizumab Versus Doublets Plus Bevacizumab as Initial Therapy of Unresectable Metastatic Colorectal Cancer.
    J Clin Oncol. 2020 Aug 20:JCO2001225. doi: 10.1200/JCO.20.01225.
    PubMed         Abstract available


    J Surg Oncol

  22. KAWAKATSU S, Mise Y, Hiratsuka M, Inoue Y, et al
    Clinical significance of subcentimeter pulmonary nodules in patients undergoing hepatectomy for colorectal liver metastases.
    J Surg Oncol. 2020;122:523-528.
    PubMed         Abstract available


    Oncogene

  23. BARTOLOME RA, Pintado-Berninches L, Jaen M, de Los Rios V, et al
    SOSTDC1 promotes invasion and liver metastasis in colorectal cancer via interaction with ALCAM/CD166.
    Oncogene. 2020 Aug 15. pii: 10.1038/s41388-020-01419.
    PubMed         Abstract available


    PLoS One

  24. STROUS MTA, Daniels AM, Zimmermann FM, van Erning FN, et al
    Is pre-operative heart rate variability a prognostic indicator for overall survival and cancer recurrence in patients with primary colorectal cancer?
    PLoS One. 2020;15:e0237244.
    PubMed         Abstract available

  25. BADDER LM, Hollins AJ, Herpers B, Yan K, et al
    3D imaging of colorectal cancer organoids identifies responses to Tankyrase inhibitors.
    PLoS One. 2020;15:e0235319.
    PubMed         Abstract available


    Proc Natl Acad Sci U S A

  26. ITATANI Y, Yamamoto T, Zhong C, Molinolo AA, et al
    Suppressing neutrophil-dependent angiogenesis abrogates resistance to anti-VEGF antibody in a genetic model of colorectal cancer.
    Proc Natl Acad Sci U S A. 2020 Aug 19. pii: 2008112117.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Colorectal Neoplasms is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: